Skip to main content

Ask
Chats
Search
Hearings
Cases
Datasets
Blog
Pricing
Docs

RevitaLid Pharmaceutical Corp. Bankruptcy Case

R

RevitaLid Pharmaceutical Corp.

Case No. 23-11704 · Delaware · Petition Date Oct 12, 2023

Ask about this case Track this case View full case profile Get updates on this case

OverviewFilingsHearings PartiesFinancialsPlan

Key Professionals

Financial Advisor

Ernst & Young

Investment Banker

Ducera Partners

Attorneys for the Debtors

Ropes & Gray

Claims and Noticing Agent

Kroll Restructuring Administration, LLC

Coverage

White & Case LLP·Jan 21, 2026

Andres Liivak | White & Case LLP

White & Case LLP·Dec 6, 2024

Judah Frogel | Partner | White & Case LLP - Law Firm

Becker's ASC·Apr 17, 2024

38 healthcare bankruptcies in 5 years

Bankrupt.com·Apr 7, 2024

231020.mbx - Bankrupt.com

Market Scope·Mar 15, 2024

Athyrium Takes Control of Upneeq Maker RVL Inc. as Parent Winds ...

Tobialaw·Feb 6, 2024

2023 Chapter 11 Filings in Delaware Bankruptcy Court (Part 2)

Onenewspage·Nov 27, 2023

RVL Completes Financial Restructuring - One News Page

citybiz·Nov 27, 2023

RVL Completes Financial Restructuring - citybiz

BioSpace·Nov 27, 2023

RVL Completes Financial Restructuring

GlobeNewswire·Nov 27, 2023

RVL Completes Financial Restructuring - GlobeNewswire

Nasdaq·Nov 27, 2023

RVL Completes Financial Restructuring

Yahoo Finance·Nov 27, 2023

RVL Completes Financial Restructuring

White & Case LLP·Nov 27, 2023

White & Case Advises Athyrium Capital Management on ...

White & Case LLP·Nov 27, 2023

Scott Greissman | Partner

Law360·Nov 20, 2023

Pharma Co. RevitaLid Approved For Ch. 11 Equity Swap Plan

petition11.com·Oct 22, 2023

Rite-Aid. Finally. - PETITION

petition11.com·Oct 22, 2023

New Chapter 11 Bankruptcy Filing - RevitaLid Pharmaceutical Corp ...

marketscreener.com·Oct 12, 2023

RVL Pharmaceuticals plc Announces Prepackaged ...

citybiz·Oct 12, 2023

RVL Pharmaceuticals Announces Prepackaged Reorganization of ...

Bloomberg Law·Oct 12, 2023

RVL Pharma's Units File Bankruptcy, Shares to Be Canceled (1)

Case No.: 23-11704
Court: Delaware
Judge: Brendan Linehan Shannon
Petition Date: Oct 12, 2023
Assets: $10,000,001-$50 million
Liabilities: $1,000,000,001-$10 billion
Industry: Healthcare
Debtors: 3

RevitaLid Pharmaceutical Corp. is a Bridgewater, New Jersey-based specialty pharmaceutical company focused on ocular medicine and medical aesthetics. The company develops and commercializes Upneeq®, an FDA-approved non-surgical ophthalmic solution for treating acquired blepharoptosis in adults. Its intellectual property portfolio includes 25 U.S. patents, 50 international patents, and 28 pending applications. The company maintains international operations across Ireland, Bermuda, Hungary, and Argentina, employing approximately 100 people.